Epineuron SR Tablet is a combination pharmaceutical formulation containing Epalrestat 150 mg and Methylcobalamin 1500 mcg, designed for the management of diabetic neuropathy and related peripheral nerve disorders. Epalrestat, an aldose reductase inhibitor, acts by preventing the accumulation of sorbitol in nerve tissues, thereby reducing oxidative stress and improving nerve function. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal metabolism. The sustained-release (SR) formulation ensures a controlled and prolonged release of active ingredients, optimizing therapeutic efficacy and improving patient compliance by reducing dosing frequency. Epineuron SR is indicated for patients experiencing symptoms such as numbness, tingling, burning sensations, and pain associated with diabetic peripheral neuropathy. Clinical studies have demonstrated that the combination effectively alleviates neuropathic symptoms, improves nerve conduction velocity, and enhances quality of life. The medication should be administered under medical supervision, with dosage adjustments based on clinical response and renal function. Common side effects may include gastrointestinal discomfort and allergic reactions, which should be promptly reported to a healthcare provider. Epineuron SR Tablet represents a comprehensive approach to neuropathic pain management by combining neuroprotective and neurotrophic mechanisms.